Market research
CNC Centene Corp
NYSE USD Healthcare
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 33B
- P/E ratio
- 23.61
- Analyst target
- 73.5
- Dividend yield
- Not available
- Beta
- 1.13
Profile
Instrument facts
- Exchange
- NYSE
- Currency
- USD
- Sector
- Healthcare
- Industry
- Healthcare Plans
- ISIN
- Not available
- Market cap
- 33B
- P/E ratio
- 23.61
- Analyst target
- 73.5
- Dividend yield
- Not available
- Beta
- 1.13
About
About Centene Corp
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.
Research context
Centene Corp appears in PyInvesting’s US Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- USD
- Sector
- Healthcare
- Industry
- Healthcare Plans
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the CNC discussion.
5 years, 6 months ago
Centene Corporation is currently in a long term uptrend where the price is trading 11.9% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.3.
Centene Corporation's total revenue rose by 50.0% to $28B since the same quarter in the previous year.
Its net income has dropped by 105.7% to $-12M since the same quarter in the previous year.
Finally, its free cash flow grew by 426.1% to $3B since the same quarter in the previous year.
Based on the above factors, Centene Corporation gets an overall score of 4/5.